These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3857128)

  • 1. Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases.
    Eerdekens MW; Nouwen EJ; Pollet DE; Briers TW; De Broe ME
    Clin Chem; 1985 May; 31(5):687-90. PubMed ID: 3857128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human placental alkaline phosphatase in benign and malignant ovarian neoplasia.
    Nouwen EJ; Pollet DE; Schelstraete JB; Eerdekens MW; Hänsch C; Van de Voorde A; De Broe ME
    Cancer Res; 1985 Feb; 45(2):892-902. PubMed ID: 3967249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum.
    De Broe ME; Pollet DE
    Clin Chem; 1988 Oct; 34(10):1995-9. PubMed ID: 3168210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung.
    Nouwen EJ; Pollet DE; Eerdekens MW; Hendrix PG; Briers TW; De Broe ME
    Cancer Res; 1986 Feb; 46(2):866-76. PubMed ID: 3510076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
    Wu JT; Miya T; Knight JA; Knight DP
    Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical studies of human placental alkaline phosphatase in normal and neoplastic tissues.
    Vengerov YuYu ; Gudima SO; Voronov AV; Votrin II
    Adv Enzyme Regul; 1988; 27():345-54. PubMed ID: 3074631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
    Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
    Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers in mammary carcinoma. An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50.
    Rasmuson T; Björk GR; Damber L; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Oncol; 1987; 26(4):261-7. PubMed ID: 3479987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma.
    Ward BG; Cruickshank DJ; Tucker DF; Love S
    Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.
    Heinonen PK; Kallioniemi OP; Koivula T
    Tumori; 1987 Jun; 73(3):301-2. PubMed ID: 3474819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
    Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-antigen immunoassay for human placental alkaline phosphatase in serum and tissue extracts, and its application as a tumor marker.
    Pollet DE; Nouwen EJ; Schelstraete JB; Renard J; Van de Voorde A; De Broe ME
    Clin Chem; 1985 Jan; 31(1):41-5. PubMed ID: 3880680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum CA 19-9 and CEA levels in a population at high risk for colorectal cancer.
    Goldberg EM; Simunovic LM; Drake SL; Mueller WF; Verrill HL
    Hybridoma; 1989 Oct; 8(5):569-75. PubMed ID: 2807313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of tumor markers in cancer of the ovary.
    Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
    [No Abstract]   [Full Text] [Related]  

  • 19. BR-MA, OM-MA, GI-MA and CEA: clinical evaluation using the IMMULITE analyzer.
    van Dalen A
    Tumour Biol; 1999; 20(3):117-29. PubMed ID: 10213919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.